All News

Taking hormone replacement therapy (HRT) for at least 6 months after total knee arthroplasty (TKA) or total hip arthroplasty (THA) may reduce risk of repeat surgery. So say the results of a community-based cohort study of women in the UK who had undergone TKA or THA for osteoarthritis.

A small, preliminary study suggests that measurement of heat changes in blood proteins may have potential in detection and staging of cervical cancer. Published in PLoS One, the report describes what may be a unique plasma thermal profile for different disease stages that could help distinguish them from healthy tissue.

An increasing number of American adolescents lack herpes simplex virus (HSV) type 1 antibodies, making them more susceptible to genital herpes following sexual debut, according to a recent study in The Journal of Infectious Diseases.

Women exposed to intimate partner violence (IPV) are likely to terminate a pregnancy, according to a recent study in PLoS Medicine. Intimate partner violence was also associated with a woman not wanting her partner to know about the pregnancy’s termination.

The key to diagnosing vulvovaginitis in young girls is a good exam and cultures. Poor hygiene is generally the culprit, but other irritants or conditions must be considered.

Women with a diagnosed fear of childbirth are at an increased risk of postpartum depression (PPD), according to a new study in BMJ Open.

A toddler’s muscle strength may owe something to its mother’s intake of vitamin D during pregnancy, according to results of an observational study by UK investigators published in the Journal of Clinical Endocrinology and Metabolism. Vitamin D has been implicated in postnatal muscle function before but little is known about how antenatal exposure impacts programming of muscle development.

Results of a Phase II study suggest that romosozumab significantly increases bone mineral density (BMD) in the lumbar spine, total hip, and femoral neck. Exploratory analyses showed the BMD increases in the lumbar spine and hip were significantly higher with romosozumab than alendronate sodium and teriparatide in postmenopausal women with low BMD.